ORVIMID, created in 2003 (United States), from 126 sister brands and 17478 competing brands. ORVIMID is a brand of Celgene, listed on the stock exchange of New York. ORVIMID is part of the Drug Manufacturers activity sector.

ORVIMID is a brand of Celgene () Sustainability

International deposit : 2003 Business sector Drug Manufacturers
Here is the evolution of interest in Celgene "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "ORVIMID sustainability"
Sustainability -> Share price